Naphthalenes
eMolecules ChemScene 2-Chloro-4-nitropyridine 25g 536855164 CS-W010890 23056-36-2 MFCD00661454 158.540 C5H3ClN2O2
ChemScene 2-Chloro-4-nitropyridine 25g 536855164 CS-W010890 23056-36-2 MFCD00661454 158.540 C5H3ClN2O2
eMolecules Ambeed / 36-Dimethyl-1245-tetrazine / 100mg / 682928848 / A1369174 / / 1558-23-2 / MFCD09866053 / 110.120 / C4H6N4
Ambeed / 36-Dimethyl-1245-tetrazine / 100mg / 682928848 / A1369174 / / 1558-23-2 / MFCD09866053 / 110.120 / C4H6N4
eMolecules Synthonix 35-Dimethylbenzylmagnesium bromide 0.25 M in 2-MeTHF 25ml 627353590 D69881 111823-36-0 MFCD01319908 223.396 C9H11BrMg
Synthonix 35-Dimethylbenzylmagnesium bromide 0.25 M in 2-MeTHF 25ml 627353590 D69881 111823-36-0 MFCD01319908 223.396 C9H11BrMg
eMolecules Synthonix 5-Chloro-2-methoxyphenylzinc iodide 0.50 M in THF 25ml 627353569 C73259 737797-36-3 MFCD02260171 333.860 C7H6ClIOZn
Synthonix 5-Chloro-2-methoxyphenylzinc iodide 0.50 M in THF 25ml 627353569 C73259 737797-36-3 MFCD02260171 333.860 C7H6ClIOZn
eMolecules Synthonix - Stock 35-Dimethylbenzylmagnesium bromide 0.25 M in 2-MeTHF 100ml 507876785 D69881 111823-36-0 MFCD01319908 223.396 C9H11BrMg
Synthonix - Stock 35-Dimethylbenzylmagnesium bromide 0.25 M in 2-MeTHF 100ml 507876785 D69881 111823-36-0 MFCD01319908 223.396 C9H11BrMg
eMolecules Synthonix 5-Chloro-2-methoxyphenylzinc iodide 0.50 M in THF 50ml 532652718 C73259 737797-36-3 MFCD02260171 333.860 C7H6ClIOZn
Synthonix 5-Chloro-2-methoxyphenylzinc iodide 0.50 M in THF 50ml 532652718 C73259 737797-36-3 MFCD02260171 333.860 C7H6ClIOZn
eMolecules Synthonix 5-Chloro-2-methoxyphenylzinc iodide 0.50 M in THF 100ml 532652719 C73259 737797-36-3 MFCD02260171 333.860 C7H6ClIOZn
Synthonix 5-Chloro-2-methoxyphenylzinc iodide 0.50 M in THF 100ml 532652719 C73259 737797-36-3 MFCD02260171 333.860 C7H6ClIOZn
eMolecules Synthonix - Stock 35-Dimethylbenzylmagnesium bromide 0.25 M in 2-MeTHF 50ml 507876784 D69881 111823-36-0 MFCD01319908 223.396 C9H11BrMg
Synthonix - Stock 35-Dimethylbenzylmagnesium bromide 0.25 M in 2-MeTHF 50ml 507876784 D69881 111823-36-0 MFCD01319908 223.396 C9H11BrMg
eMolecules Combi-Blocks 35-Dibromo-4-nitro-1H-pyrazole 25g 439369099 QB-6241 96.000 104599-36-2 MFCD09972275 270.868 C3HBr2N3O2
Combi-Blocks 35-Dibromo-4-nitro-1H-pyrazole 25g 439369099 QB-6241 96.000 104599-36-2 MFCD09972275 270.868 C3HBr2N3O2
Apexbio Technology LLC Acetate gossypol 12542-36-8 50mg
Acetate gossypol (CAS 12542-36-8) is a polyphenolic compound isolated from the seeds and bark of Gossypium herbaceum L It functions primarily as an inhibitor of anti-apoptotic Bcl-2 family proteins thereby promoting apoptosis in various cancer cell types By disrupting mitochondrial membrane potential and modulating cell survival pathways acetate gossypol has been utilized in studies investigating mechanisms of programmed cell death and antitumor activity This compound is frequently employed as a molecular tool in cancer biology and apoptosis research Store under sealed cool and dry conditions to ensure stability
Apexbio Technology LLC BI-847325 1207293-36-4 10mg
BI-847325 (CAS 1207293-36-4) is a dual inhibitor targeting MEK1/2 and Aurora kinases with reported IC50 values of 25 nM and 4 nM against MEK1 and MEK2 and 3 nM 25 nM and 15 nM against Aurora A B and C respectively By inhibiting these kinases BI-847325 disrupts the MAPK/ERK and cell cycle signaling pathways that regulate cell proliferation and survival In cellular assays it demonstrates nanomolar EC50 values for inhibition of pERK and pHH3 in KRAS- and BRAF-mutant cancer cell lines and potently suppresses proliferation across a wide range of tumor cell models In xenograft studies it fully blocks tumor growth in BRAF- and KRAS-mutant cancer models This compound is utilized in research on kinase-targeted cancer therapies
Apexbio Technology LLC BI-847325 1207293-36-4 5mg
BI-847325 (CAS 1207293-36-4) is a dual inhibitor targeting MEK1/2 and Aurora kinases with reported IC50 values of 25 nM and 4 nM against MEK1 and MEK2 and 3 nM 25 nM and 15 nM against Aurora A B and C respectively By inhibiting these kinases BI-847325 disrupts the MAPK/ERK and cell cycle signaling pathways that regulate cell proliferation and survival In cellular assays it demonstrates nanomolar EC50 values for inhibition of pERK and pHH3 in KRAS- and BRAF-mutant cancer cell lines and potently suppresses proliferation across a wide range of tumor cell models In xenograft studies it fully blocks tumor growth in BRAF- and KRAS-mutant cancer models This compound is utilized in research on kinase-targeted cancer therapies
Apexbio Technology LLC BI-847325 1207293-36-4 100mg
BI-847325 (CAS 1207293-36-4) is a dual inhibitor targeting MEK1/2 and Aurora kinases with reported IC50 values of 25 nM and 4 nM against MEK1 and MEK2 and 3 nM 25 nM and 15 nM against Aurora A B and C respectively By inhibiting these kinases BI-847325 disrupts the MAPK/ERK and cell cycle signaling pathways that regulate cell proliferation and survival In cellular assays it demonstrates nanomolar EC50 values for inhibition of pERK and pHH3 in KRAS- and BRAF-mutant cancer cell lines and potently suppresses proliferation across a wide range of tumor cell models In xenograft studies it fully blocks tumor growth in BRAF- and KRAS-mutant cancer models This compound is utilized in research on kinase-targeted cancer therapies
Apexbio Technology LLC BI-847325 1207293-36-4 50mg
BI-847325 (CAS 1207293-36-4) is a dual inhibitor targeting MEK1/2 and Aurora kinases with reported IC50 values of 25 nM and 4 nM against MEK1 and MEK2 and 3 nM 25 nM and 15 nM against Aurora A B and C respectively By inhibiting these kinases BI-847325 disrupts the MAPK/ERK and cell cycle signaling pathways that regulate cell proliferation and survival In cellular assays it demonstrates nanomolar EC50 values for inhibition of pERK and pHH3 in KRAS- and BRAF-mutant cancer cell lines and potently suppresses proliferation across a wide range of tumor cell models In xenograft studies it fully blocks tumor growth in BRAF- and KRAS-mutant cancer models This compound is utilized in research on kinase-targeted cancer therapies
Apexbio Technology LLC BI-847325 1207293-36-4 25mg
BI-847325 (CAS 1207293-36-4) is a dual inhibitor targeting MEK1/2 and Aurora kinases with reported IC50 values of 25 nM and 4 nM against MEK1 and MEK2 and 3 nM 25 nM and 15 nM against Aurora A B and C respectively By inhibiting these kinases BI-847325 disrupts the MAPK/ERK and cell cycle signaling pathways that regulate cell proliferation and survival In cellular assays it demonstrates nanomolar EC50 values for inhibition of pERK and pHH3 in KRAS- and BRAF-mutant cancer cell lines and potently suppresses proliferation across a wide range of tumor cell models In xenograft studies it fully blocks tumor growth in BRAF- and KRAS-mutant cancer models This compound is utilized in research on kinase-targeted cancer therapies